聯得裝備(300545.SZ):擬定增募資不超8億元 控股股東參與認購
格隆匯4月28日丨聯得裝備(300545.SZ)披露2020年度非公開發行A股股票預案,發行對象為包括控股股東、實控人聶泉在內的不超過35名特定對象;發行價格不低於定價基準日前20個交易日發行人股票交易均價的80%;發行數量不超約4322.62萬股,其中聶泉所認購股份的鎖定期為18個月,其他特定對象所認購股份的鎖定期為6個月;募資總額不超8億元,擬投向汽車電子顯示智能裝備建設項目、大尺寸TV模組智能裝備建設項目、半導體封測智能裝備建設項目及補充流動資金項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.